<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2198">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04556513</url>
  </required_header>
  <id_info>
    <org_study_id>QUENOT 2020</org_study_id>
    <nct_id>NCT04556513</nct_id>
  </id_info>
  <brief_title>Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status</brief_title>
  <acronym>RECOVIDS</acronym>
  <official_title>Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators are attempting to evaluate the influence of socio-economic
      factors on the functional recovery (physical and psychological) of patients who developed
      ARDS after a COVID-19 infection, with the aim of offering personalized medical and social
      follow-up and support measures in order to avoid medium- and long-term complications, which
      can result in handicaps, reduced quality of life, and a higher risk of death.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 18, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory sequelae 6 months after resuscitation.</measure>
    <time_frame>Through study completion, an average of 6 months</time_frame>
    <description>Defined by the presence of at least one of the following :
An alteration of the alveolar-capillary diffusion of CO &lt;80% of the predicted normal values
And/or a forced vital capacity &lt;80% of predicted normal values
and/or O2 desaturation in the 6-minute walk test
And/or pulmonary parenchymatous disease with fibrosis in tomodensitometry.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Covid19</condition>
  <condition>ARDS</condition>
  <condition>Functional Recovery</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <description>Patient hospitalized in ICU for PCR-proven SARS-COV-2 infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Paraclinical examination</intervention_name>
    <description>Respiratory functional tests</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical Examination</intervention_name>
    <description>Clinical Examination</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Semi-directive interview</intervention_name>
    <description>By phone</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>quality of life questionnaires</intervention_name>
    <description>SF36, VSRQ, IESR, HADS</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who has been managed in intensive care for covid-19 infection.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inpatient in ICU for PCR-proven SARS-VOC-2 infection regardless of specimen type

          -  Patient who received a chest CT scan in the initial phase of management (either just
             before or during hospitalization in the intensive care unit)

          -  Patient who has received invasive or non-invasive ventilatory support, or humidified
             and heated high-flow oxygen (HFO).

          -  ARDS meeting the criteria of the 2012 Berlin definition. For patients who have
             received only HFO, a flow rate at least equal to 50L/minute with a FiO2 strictly
             greater than 50% with a PaO2/FiO2 ratio less than or equal to 200 will be required for
             inclusion.

          -  Patient who gave oral consent after being informed about the conduct of this study.

        Exclusion Criteria:

          -  Patient with limited autonomy prior to hospitalization in limited intensive care unit:
             walking distance of less than 50 meters, WHO classification status 3 and 4.

          -  Patient with a history of chronic respiratory failure as defined by the use of
             long-term oxygen therapy or non-invasive home ventilation, excluding patients with SAS
             and/or hypoventilation obesity syndrome.

          -  Patient with a history of central or peripheral neurological conditions limiting the
             patient's motor autonomy and the performance on gait tests or Pulmonary function Tests

          -  Patient refusing to participate

          -  Patient &lt; 18 years of age

          -  Patient not affiliated or not benefiting from national health insurance

          -  Patient under guardianship, curatorship or protected adult

          -  Patient unable to understand and consent to the research protocol

        SECONDARY EXCLUSION CRITERIA

          -  Patient not showing up for visit at M6

          -  Patients who have not had all the examinations necessary to evaluate the main endpoint
             (Spirometry, DLCO, TM6 and CT)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Pierre QUENOT</last_name>
    <phone>0380293685</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-pierre.quenot@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre QUENOT</last_name>
      <phone>0380293685</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-pierre.quenot@chu-dijon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierre-Louis DECLERCQ</last_name>
      <phone>0232147550</phone>
      <phone_ext>+33</phone_ext>
      <email>pdeclercq@ch-dieppe.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>September 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2020</study_first_posted>
  <last_update_submitted>September 21, 2020</last_update_submitted>
  <last_update_submitted_qc>September 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

